|
⚲
|
| Keyboard |
| Sofinnova Management IX LLC
✚
|
|
|---|---|
| CIK # | 0001612134 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001612134] | |
| 4 | [0001612134] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Checkmate Pharmaceuticals Inc CMPI
Common Stock
|
2020-08-11 | Conversion | 3,473,374 | ||
|
Checkmate Pharmaceuticals Inc CMPI
Series A Preferred Stock · derivative
|
2020-08-11 | Conversion | 12,500,000 | $0.00 | |
|
Checkmate Pharmaceuticals Inc CMPI
Series B Preferred Stock · derivative
|
2020-08-11 | Conversion | 8,753,350 | $0.00 | |
|
Checkmate Pharmaceuticals Inc CMPI
Series C Preferred Stock · derivative
|
2020-08-11 | Conversion | 3,644,624 | $0.00 | |
|
Checkmate Pharmaceuticals Inc CMPI
Common Stock
|
2020-08-11 | Buy | 133,333 | $15.00 | 1,999,995 |
|
Iterum Therapeutics Ltd ITRM
Ordinary Shares
|
2020-06-02 | Sell | 400,000 | $1.61 | 644,000 |
|
Iterum Therapeutics Ltd ITRM
Ordinary Shares
|
2020-06-01 | Sell | 100,000 | $1.69 | 169,000 |
|
Iterum Therapeutics Ltd ITRM
6.500% Exchangeable Senior Subordinated Note due 2025 · derivative
|
2020-01-21 | Grant | $1,750,000.00 | ||
|
NextCure Inc NXTC
Common Stock
|
2019-11-15 | Buy | 150,000 | $36.75 | 5,512,500 |
|
Galera Therapeutics Inc GRTX
Series B-2 Preferred Stock · derivative
|
2019-11-12 | Conversion | 9,090,909 | ||
|
Galera Therapeutics Inc GRTX
Common Stock
|
2019-11-12 | Buy | 750,000 | $12.00 | 9,000,000 |
|
Galera Therapeutics Inc GRTX
Series C Preferred Stock · derivative
|
2019-11-12 | Conversion | 2,709,659 | ||
|
Galera Therapeutics Inc GRTX
Common Stock
|
2019-11-12 | Conversion | 2,333,712 | ||
|
NextCure Inc NXTC
Common Stock
|
2019-05-13 | Conversion | 278,759 | ||
|
NextCure Inc NXTC
Series B-1 Preferred Stock · derivative
|
2019-05-13 | Conversion | 3,773,585 | ||
|
NextCure Inc NXTC
Series A-3 Preferred Stock · derivative
|
2019-05-13 | Conversion | 7,301,000 | ||
|
NextCure Inc NXTC
Series A-2 Preferred Stock · derivative
|
2019-05-13 | Conversion | 3,732,500 | ||
|
NextCure Inc NXTC
Series A-1 Preferred Stock · derivative
|
2019-05-13 | Conversion | 2,239,500 | ||
|
NextCure Inc NXTC
Common Stock
|
2019-05-13 | Conversion | 464,599 | ||
|
NextCure Inc NXTC
Common Stock
|
2019-05-13 | Conversion | 908,785 | ||
| showing 20 of 37 most recent transactions | |||||